Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab + Dexamethasone in R/R CLL
NCT01310101Phase 2Completed
- Sponsor
- Fakultní nemocnice Brno
- Start
- Apr 2011
- Primary completion
- Feb 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic lymphocytic leukemia (CLL), sponsored by Fakultní nemocnice Brno. Started Apr 2011; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01310101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310101.